Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 12 results:
Author Title Type [ Year] Filters: Keyword is Enzyme Inhibitors [Clear All Filters]
Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia..
Kidney Int. 94(4), 830-831.
(2018). Synthesis and characterization of the first inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD)..
Chem Commun (Camb). 53(95), 12814-12817.
(2017). Microcystin LR Shows Cytotoxic Activity Against Pancreatic Cancer Cells Expressing the Membrane OATP1B1 and OATP1B3 Transporters..
Anticancer Res. 35(11), 5857-65.
(2015). Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy..
Expert Rev Cardiovasc Ther. 13(9), 1059-66.
(2015).
(2014).
(2013).
Rational targeting in acute promyelocytic leukemia..
In Vivo. 24(1), 21-7.
(2010). Comparative analysis of four beta-galactosidases from Bifidobacterium bifidum NCIMB41171: purification and biochemical characterisation..
Appl Microbiol Biotechnol. 82(6), 1079-88.
(2009). Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications..
Invest Ophthalmol Vis Sci. 50(9), 4072-9.
(2009). Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro..
Thorac Cardiovasc Surg. 56(2), 77-82.
(2008). Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro..
J Clin Endocrinol Metab. 91(10), 4013-21.
(2006). Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas..
J Clin Endocrinol Metab. 88(11), 5392-8.
(2003).